Have we seen the reporting of the ARDS post infection treatment data before? I don't think I have noticed this reported before at least. It sounds like the PPS may be very good at taming the cytokine storm of the Covid 19 post viral stages. Given we are going to be living with endemic Covid for years I reckon this could be big.
Positive Top-line Results in ARDS Preclinical Study: PPS at the post-acute phase of viral
infection (21-days post infection) demonstrated a statistically significant reduction in
pulmonary collagen compared to vehicle treated groups based on histological staining of
collagen. PPS administered subcutaneously at Day 0 at 3mg/kg resulted in a statistically
significant reduction in inflammatory cell infiltrates in the lungs at 8 days post infection.
- Forums
- ASX - By Stock
- PAR
- Ann: Quarterly Update and Appendix 4C - quarterly
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
2.44%
!
42.0¢

Ann: Quarterly Update and Appendix 4C - quarterly, page-9
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
42.0¢ |
Change
0.010(2.44%) |
Mkt cap ! $166.9M |
Open | High | Low | Value | Volume |
40.0¢ | 42.0¢ | 40.0¢ | $168.2K | 411.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3500 | 41.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
42.0¢ | 50665 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3500 | 0.410 |
1 | 1235 | 0.405 |
5 | 66500 | 0.400 |
4 | 67519 | 0.395 |
5 | 56650 | 0.390 |
Price($) | Vol. | No. |
---|---|---|
0.420 | 50665 | 2 |
0.425 | 2860 | 1 |
0.430 | 28500 | 1 |
0.440 | 45000 | 2 |
0.445 | 1400 | 1 |
Last trade - 16.11pm 18/07/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |